Skip to main content

Table 4 Logistic regression for mortality

From: Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience

Risk factors p-value OR 95% CI for OR
Lower Upper
Age 0.22 2.15 0.64 7.27
Female gender 0.38 0.54 0.14 2.10
FIB-4 0.006 4.14 1.49 11.49
Albumin < 3.5 0.89 1.11 0.26 4.75
  1. p ≤ 0.05 is significant